相关实验视频

Updated: May 27, 2025

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

针对结核病的外膜蛋白 (OmpA) 的保护性单克隆抗体的分离和表征

Huoming Li¹, Jiahong Ji¹, Mengjin Qu²

¹National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Microbiology spectrum

|February 18, 2025

概括

研究人员确定了一种针对Mycobacterium结核病外膜蛋白A (OmpA) 的保护性抗体. 这种抗体在小鼠中证明了安全性和有效性,为耐药结核病治疗和疫苗开发提供了潜力.

科学领域:

免疫学免疫学免疫学
微生物学微生物学
传染性疾病传染性疾病

背景情况:

由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 是一个重要的全球性动物性疾病.
已知Mtb的表面抗原可诱导保护性抗体,但其表征尚不完整.
针对Mtb表面蛋白的抗体可以增强宿主抗感染防御机制.

研究的目的:

识别和表征一种向mtb外膜蛋白A (OmpA) 的保护性抗体.
评估已识别的抗体对潜在的结核病治疗和疫苗开发的疗效和安全性.

主要方法:

针对Mtb抗原的保护性抗体的查,重点关注OmpA.
在体外测定细胞,细胞内杀死和细胞.
在小鼠体内实验,包括细菌负载减小,毒性和药物动力学评估.

主要成果:

一种针对OmpA的保护性单克隆抗体 (mAb 1E1),IgG2b同型,被确定具有高标位.
mAb 1E1增强了opsonophagocytosis,发酵体-溶解体融合,并抑制了细胞内Mtb的生长.
活体研究显示,细菌负载显著减少 (0.7-1.0 log),并证实了抗体的安全性和持续有效性.

结论:

OmpA引起保护性抗体,mAb 1E1在小鼠中显示出对结核病的显著治疗和预防潜力.
鉴定出的抗体显示出作为耐药结核病治疗策略的前景.
OmpA是未来结核病疫苗开发的潜在候选抗原.

关键词:

这就是OmpaA.幽默免疫力幽默免疫力这是一种单克隆抗体.发细胞的形成发细胞症结核病是一种肺结核病.

更多相关视频

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Method for the Isolation of Francisella tularensis Outer Membranes

Method for the Isolation of Francisella tularensis Outer Membranes

Published on: June 29, 2010

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...